Summary:
- The article critically examines the appointment of individuals with ties to "biomed" autism advocacy—a movement frequently associated with pseudoscientific treatments—to leadership positions within the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- It highlights concerns regarding the potential shift of federal research priorities away from evidence-based medicine and toward controversial, unproven interventions that lack rigorous scientific validation.